Oncologie

Phase I Study of Paclitaxel and Epirubicin in Patients With Metastatic Breast Cancer : a Preliminary Report on Safety

Seminars in Oncology – Vol 23, N°1, February 96, p. 24-27 Catimel G, Spielmann M, Dieras V, Kayitalire L, Pouillart P, Guastalla J-P, Soler-Michel P, Graffand N, Garet F, Dumortier F, Pellae-Cosset B and Chazard M.

Vous souhaitez échanger
avec nos équipes

Contactez-nous

D’autres articles qui pourraient
vous intéresser

Risk Factors TFR CP-CML
Success stories - Oncologie - Facultatif

Identification of Individual Risk Factors for Treatment Free Remission (TFR) Failure in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients

Long-Term TKI Treatment Patterns
Success stories - Oncologie - Facultatif

Tyrosine Kinase Inhibitor (TKI) Treatment Patterns in 5,261 Chronic Phase (CP) Chronic Myeloid Leukemia (CML) Patients in “Real-Life”

Use of Digital Health Technology to Enable Drug Development
Oncologie

Use of Digital Health Technology to Enable Drug Development